Group One Trading’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,500
Closed -$84.3K 8499
2023
Q1
$84.3K Sell
8,500
-36,300
-81% -$360K ﹤0.01% 4443
2022
Q4
$447K Buy
44,800
+31,900
+247% +$238K ﹤0.01% 3149
2022
Q3
$71K Sell
12,900
-23,800
-65% -$132K ﹤0.01% 5108
2022
Q2
$134K Buy
36,700
+15,900
+76% +$75.2K ﹤0.01% 4705
2022
Q1
$126K Buy
20,800
+16,000
+333% +$97.5K ﹤0.01% 5277
2021
Q4
$40K Sell
4,800
-10,500
-69% -$91.7K ﹤0.01% 6506
2021
Q3
$139K Buy
15,300
+900
+6% +$7.74K ﹤0.01% 5562
2021
Q2
$117K Buy
14,400
+14,300
+14,300% +$98.1K ﹤0.01% 5809
2021
Q1
$1K Buy
+100
New +$495 ﹤0.01% 7498
2016
Q1
Sell
-36
Closed -$1K 5084
2015
Q4
$1K Sell
36
-61
-63% -$1.03K ﹤0.01% 4633
2015
Q3
$1K Sell
97
-32
-25% -$610 ﹤0.01% 4784
2015
Q2
$3K Sell
129
-114
-47% -$11.3K ﹤0.01% 4628
2015
Q1
$46K Buy
+243
New +$55.8K ﹤0.01% 3412

Group One Trading's APEN Position: Q1 2023 in Review

Group One Trading sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 360 shares — an estimated $3.57K sold.

Group One Trading first reported a position in APEN in Q3 2013 and held it in 11 quarters. The position peaked at $29K in Q1 2015. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Group One Trading reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 360 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $3.57K.
  • Group One Trading first reported a position in Apollo Endosurgery, Inc. in Q3 2013 and held it in 11 quarters.
  • Group One Trading's Apollo Endosurgery, Inc. position peaked at $29K in Q1 2015.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.